We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+3.08%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$464M
AUM Growth
+$254K
Cap. Flow
-$11.5M
Cap. Flow %
-2.48%
Top 10 Hldgs %
46.69%
Holding
69
New
–
Increased
32
Reduced
23
Closed
5

Top Buys

Rank Stock Value
1
GNTX icon
Gentex
GNTX
+$5.51M
2
WBA
Walgreens Boots Alliance
WBA
+$4.42M
3
PEP icon
PepsiCo
PEP
+$2.84M
4
WFC icon
Wells Fargo
WFC
+$1.71M
5
COL
Rockwell Collins
COL
+$1.67M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$14.9M
2
VZ icon
Verizon
VZ
+$9.42M
3
BHI
Baker Hughes
BHI
+$3.91M
4
BAX icon
Baxter International
BAX
+$3.16M
5
SYT
Syngenta Ag
SYT
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 29.4%
2 Technology 18.16%
3 Industrials 17.16%
4 Financials 12.21%
5 Consumer Staples 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
1
Medtronic
MDT
$117B
$35.8M 7.71%
402,836
-177,110
-31% -$14.9M
JNJ icon
2
Johnson & Johnson
JNJ
$646B
$26.9M 5.81%
203,687
+9,600
+5% +$1.22M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$25.2M 5.43%
321,788
+53,671
+20% +$4.42M
ORCL icon
4
Oracle
ORCL
$435B
$21.9M 4.73%
437,578
+17,819
+4% +$812K
MSFT icon
5
Microsoft
MSFT
$3.81T
$21.5M 4.64%
312,037
+5,419
+2% +$372K
WFC icon
6
Wells Fargo
WFC
$262B
$20M 4.31%
360,725
+31,986
+10% +$1.71M
AON icon
7
Aon
AON
$75.4B
$20M 4.31%
150,238
+6,680
+5% +$845K
PEP icon
8
PepsiCo
PEP
$193B
$16.3M 3.51%
141,006
+24,788
+21% +$2.84M
RTX icon
9
RTX Corp
RTX
$285B
$15.1M 3.26%
196,855
+12,302
+7% +$921K
AXP icon
10
American Express
AXP
$225B
$13.9M 3%
165,274
-9,648
-6% -$763K
MSI icon
11
Motorola Solutions
MSI
$80.4B
$13.9M 3%
160,204
+7,667
+5% +$650K
UNP icon
12
Union Pacific
UNP
$183B
$13.7M 2.95%
125,490
+12,766
+11% +$1.39M
PFE icon
13
Pfizer
PFE
$159B
$13.3M 2.88%
418,748
+21,060
+5% +$664K
JCI icon
14
Johnson Controls International
JCI
$84.6B
$13.3M 2.86%
305,632
-30,576
-9% -$1.28M
COL
15
DELISTED
Rockwell Collins
COL
$12.1M 2.62%
115,616
+16,097
+16% +$1.67M
CSCO icon
16
Cisco
CSCO
$433B
$10M 2.16%
320,770
+26,961
+9% +$878K
BAX icon
17
Baxter International
BAX
$13.5B
$9.79M 2.11%
161,667
-55,635
-26% -$3.16M
TFCFA
18
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$8.58M 1.85%
302,713
+4,842
+2% +$139K
NVS icon
19
Novartis
NVS
$292B
$7.26M 1.57%
97,125
-1,784
-2% -$126K
TIF
20
DELISTED
Tiffany & Co.
TIF
$7.25M 1.56%
77,268
+3,831
+5% +$352K
CHKP icon
21
Check Point Software Technologies
CHKP
$14.1B
$7.24M 1.56%
66,353
-10,641
-14% -$1.15M
GNTX icon
22
Gentex
GNTX
$4.78B
$7.1M 1.53%
374,456
+282,935
+309% +$5.51M
GWW icon
23
W.W. Grainger
GWW
$61.5B
$6.64M 1.43%
36,810
+980
+3% +$185K
APA icon
24
APA Corp
APA
$14.9B
$6.62M 1.43%
138,045
-1,154
-0.8% -$56.9K
BTI icon
25
British American Tobacco
BTI
$121B
$6.43M 1.39%
93,828
-11,699
-11% -$813K
1
2 3

Similar funds

GC
Guidance Capital Lousville, Kentucky $468M AUM 26.09% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $468M AUM 42.57% 1-Year Est. Return
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $468M AUM 19.67% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
QFA
Quattro Financial Advisors The Woodlands, Texas $468M AUM 13.49% 1-Year Est. Return
TOCUITCONY
Trustees of Columbia University in the City of New York New York $468M AUM 20.53% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $468M AUM 30.94% 1-Year Est. Return

Foyston, Gordon, & Payne's Q2 2017 Portfolio in Review

As of Q2 2017, Foyston, Gordon, & Payne held 69 positions worth $464M, up 0.05% from $464M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Foyston, Gordon, & Payne's Q2 2017 filing shows 32 increased, 23 reduced and 5 closed positions. The largest sale was Medtronic, an estimated $14.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 30% a quarter earlier, followed by Technology and Industrials.

  • Foyston, Gordon, & Payne added most to Gentex in Q2 2017, an estimated $5.51M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2017 reduction was Medtronic, cutting an estimated $14.9M.
  • Foyston, Gordon, & Payne fully exited Syngenta Ag in Q2 2017, selling an estimated $2.5M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 47% of its $464M portfolio in Q2 2017.
  • Foyston, Gordon, & Payne opened 0 new positions and closed 5 in Q2 2017.
  • Foyston, Gordon, & Payne's portfolio value rose 0.05% quarter-over-quarter to $464M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2017, filed 14 Aug 2017.